ClerbauxG., FrancartJ., WallemacqP., RobertA., GoffinE.Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.Nephrol Dial Transplant2006; 21: 1032–9.
2.
GillerotG., GoffinE., MichelC., EvenepoelP., van BiesenW., TintillierM.Genetic and clinical factors influence the baseline permeability of the peritoneal membrane.Kidney Int2005; 67: 2477–87.
3.
RumpsfeldM., McDonaldS.P., PurdieD.M., CollinsJ., JohnsonD.W.Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients.Am J Kidney Dis2004; 43: 492–501.
4.
DaviesS.J., PhillipsL., RussellG.I.Peritoneal solute transport predicts survival on CAPD independently of residual renal function.Nephrol Dial Transplant1998; 13: 962–8.
5.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PageD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1998; 9: 1285–92.
6.
WangT., HeimburgerO., WaniewskiJ., BergstromJ., LindholmB.Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant1998; 13: 1242–9.
7.
TzamaloukasA.H., SaddlerM.S., MurphyG., MorganK., GoldmanR.S., MurataG.H.Volume of distribution and fractional clearance of urea in amputees on continuous ambulatory peritoneal dialysis.Perit Dial Int1994; 14: 356–61.
8.
KangD.H., YoonK.I., ChoiK.B., LeeR., LeeH.Y., HanD.S.Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients.Nephrol Dial Transplant1999; 14: 1715–22.
9.
YangX., FangW., BargmanJ.M., OreopoulosD.G.High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis.Perit Dial Int2008; 28: 82–92.
10.
WigginsK.J., McDonaldS.P., BrownF.G., RosmanJ.B., JohnsonD.W.High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.Nephrol Dial Transplant2007; 22: 3005–12.
11.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival.Nephrol Dial Transplant2002; 17: 1085–92.
12.
ChungS.H., HeimburgerO., StenvinkelP., BergstromJ., LindholmB.Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.Nephrol Dial Transplant2001; 16: 2240–5.
13.
MargettsP.J., McMullinJ.P., RabbatC.G., ChurchillD.N.Peritoneal membrane transport and hypoalbuminemia: cause or effect?Perit Dial Int2000; 20: 14–18.
14.
DaviesS.J.Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.Kidney Int2004; 66: 2437–45.
15.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
16.
KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease.Am J Kidney Dis2007; 49(2 Suppl 2): S12–154.
17.
HasegawaT., YoshimuraA., HiroseM., KomukaiD., TayamaH., WatanabeS.A strict low protein diet during the predialysis period suppresses peritoneal permeability at induction of peritoneal dialysis.Perit Dial Int2009; 29: 319–24.
18.
MitchW.E.Dietary protein restriction in chronic renal failure: nutritional efficacy, compliance, and progression of renal insufficiency.J Am Soc Nephrol1991; 2: 823–31.
19.
KlahrS., LeveyA.S., BeckG.J., CaggiulaA.W., HunsickerL., KusekJ.W.The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.N Engl J Med1994; 330: 877–84.
20.
KasiskeB.L., LakatuaJ.D., MaJ.Z., LouisT.A.A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function.Am J Kidney Dis1998; 31: 954–61.
21.
MeyerT.W., AndersonS., RennkeH.G., BrennerB.M.Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.J Hypertens Suppl1986; 4: S239–41.
22.
FukuiM., NakamuraT., EbiharaI., NagaokaI., TominoY., KoideH.Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis.J Lab Clin Med1993; 121: 224–34.
23.
BeavisM.J., WilliamsJ.D., HoppeJ., TopleyN.Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent.Kidney Int1997; 51: 205–15.
24.
LaiK.N., TangS.C., LeungJ.C.Mediators of inflammation and fibrosis.Perit Dial Int2007; 27(Suppl 2): S65–71.
25.
KolesnykI., DekkerF.W., NoordzijM., le CessieS., StruijkD.G., KredietR.T.Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patients.Perit Dial Int2007; 27: 446–53.
26.
NakamotoH., ImaiH., FukushimaR., IshidaY., YamanouchiY., SuzukiH.Role of the renin-angiotensin system in the pathogenesis of peritoneal fibrosis.Perit Dial Int2008; 28(Suppl 3): S83–7.
27.
FangW., OreopoulosD.G., BargmanJ.M.Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.Nephrol Dial Transplant2008; 23: 3704–10.
